Adagene Inc (ADAG)
2.64
+0.11
(+4.35%)
USD |
NASDAQ |
Apr 18, 16:00
2.64
0.00 (0.00%)
After-Hours: 20:00
Adagene Revenue (TTM): 18.11M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 18.11M |
June 30, 2023 | 22.67M |
December 31, 2022 | 9.293M |
Date | Value |
---|---|
June 30, 2022 | 12.74M |
December 31, 2021 | 10.18M |
June 30, 2021 | 1.668M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.668M
Minimum
Jun 2021
22.67M
Maximum
Jun 2023
12.44M
Average
11.46M
Median
Revenue (TTM) Benchmarks
China SXT Pharmaceuticals Inc | 1.972M |
Sinovac Biotech Ltd | 420.88M |
CASI Pharmaceuticals Inc | 33.88M |
Zai Lab Ltd | 266.72M |
I-MAB | -35.63M |